| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |